
Johnson & Johnson
JNJ 238.46 (-0.98%) 2.35
Health Care
Pharmaceuticals
Quality Checklist 6/8
5Y Shares Out Change < 0%
ROIC > 10%
Debt/Equity < 1
Current Ratio > 1
Net Margin > 10%
Est. EPS Growth > 5%
Quick Ratio > 1
Past Net Income CAGR > 0%
0.0%of Portfolio
My holdings
Day change:
Total change:
Shares:Cost basis:
Market cap: $574.36(B)
EV: $602.26(B)
Total Equity: $81.54(B)
Earnings date: Apr-14-2026
P/E: 21.42
Forward P/E: 20.66
P/FCF: 29.15
P/S: 6.09
P/B: 7.04
EPS: $11.1
EPS (fwd): $11.5
FCF/share: $8.2
Revenue/share: $39.1
Book value/share: $33.9
ROIC: 21.7%
ROA: 13.5%
ROE: 33.6%
Debt/Equity: 0.60
Current Ratio: 1.00
Gross margin: 68.1%
Operating margin: 26.2%
Net margin: 28.5%
Dividend/share: $5.1
Div. yield: 2.16%
Growth Estimates
Revenue
CAGR: 5.7%FY+1$100.63(B)
FY+2(+5.4%)$106.10(B)
FY+3(+6.5%)$112.95(B)
FY+4(+5.1%)$118.70(B)
FY+5(+5.8%)$125.60(B)
Net Income
CAGR: 8.4%FY+1$28.10(B)
FY+2(+8.7%)$30.53(B)
FY+3(+8.5%)$33.13(B)
FY+4(+7.4%)$35.57(B)
FY+5(+9.1%)$38.81(B)
EPS
CAGR: 9.0%FY+1$11.54
FY+2(+8.9%)$12.57
FY+3(+9.1%)$13.72
FY+4(+7.9%)$14.80
FY+5(+9.9%)$16.27
FCF per share
CAGR: 8.1%FY+1$10.52
FY+2(+11.1%)$11.69
FY+3(+1.9%)$11.92
FY+4(+12.3%)$13.38
FY+5(+7.3%)$14.36
